αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/NAVBQ

NAVBQ

NAVBQ — Institutional Holders Breakdown

Navidea Biopharmaceuticals I

+$0.0

Net Activity

Data as of: 2025-12-31

Institutions Holding

1

Popularity Rank

#19980

Avg Weight

0.00%

Total Value

$0.0

Ownership Trend

1 institutions currently hold NAVBQ, with 1 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

1

Key Holders

Key Holders

Top 5 by Value

FR
Front Row Advisors LLC
$0.0

Top 5 by Conviction

FR
Front Row Advisors LLC
0.00%
View all 1 holding institutions

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$0.0

Total Sell Value

New buy1
Trim0
Add0
Sold out0

1

Net Buyers

0

Net Sellers

Smart Money Convergence

NAVBQ does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2025-12-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/NAVBQ

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

63937X202

FAQ

Who are the top institutional investors holding NAVIDEA BIOPHARMACEUTICALS I (NAVBQ)?
Major stakeholders currently include Front Row Advisors LLC ($0.0). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in NAVBQ.
What is the overall institutional sentiment toward NAVBQ recently?
Institutional sentiment appears Neutral. During the most recent reporting quarter, the stock experienced a flat net capital flow.
Which institutions have been selling or reducing their NAVBQ positions?
In the latest period, no tracked funds trimmed or exited their positions in NAVBQ.
Are there any notable investors adding NAVBQ to their portfolios?
Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $0.0.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access NAVBQ's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/NAVBQ

CLI

npx alphasmo stocks get NAVBQ
Full API & MCP documentation →